Maximum Daily Dose of Candesartan
The maximum daily dose of candesartan is 32 mg once daily. 1
Dosing Information
Standard Maximum Dose
- 32 mg once daily is the established maximum dose for candesartan 1
- Doses larger than 32 mg do not appear to provide greater blood pressure lowering effect 1
Dosing Range and Titration
The typical dosing approach follows this pattern:
- Starting dose: 4-8 mg once daily (or 16 mg in non-volume depleted patients) 2, 1
- Target dose: 32 mg once daily 2, 3
- Dosing frequency: Can be administered once or twice daily with total daily doses ranging from 8-32 mg 1
Context-Specific Considerations
Heart Failure with Reduced Ejection Fraction (HFrEF)
In patients with HFrEF, the 2022 AHA/ACC/HFSA guidelines specify:
- Target dose: 32 mg once daily 2, 3
- Mean dose achieved in clinical trials: 24 mg total daily 2, 3
- Titration should occur every 1-2 weeks depending on symptoms, vital signs, and laboratory findings 2
- Achieving target doses shown in RCTs is strongly recommended (Class I, Level A) to reduce cardiovascular mortality and heart failure hospitalizations 2
Hypertension
For blood pressure control:
- Maximum effective dose remains 32 mg daily 1, 4
- Dose-response is evident across the 2-32 mg range 4
- If additional BP reduction needed beyond 32 mg candesartan, add hydrochlorothiazide rather than exceeding the candesartan maximum 1
Special Populations
Renal Impairment
- Severe renal impairment (CrCl <30 mL/min): Specific dosing recommendations cannot be provided for combination products 1
- For candesartan monotherapy in severe renal dysfunction: maximum of 8 mg/day appears suitable 5
Hepatic Impairment
- Moderate to severe hepatic impairment: Do not initiate with combination products as the appropriate 8 mg starting dose cannot be given 1
- Mild to moderate hepatic impairment: doses up to 12 mg/day do not require precautions 5
Clinical Evidence Supporting Maximum Dose
Research demonstrates that:
- The 32 mg dose represents the plateau of the dose-response curve 6
- In the CHARM trial for heart failure, patients were uptitrated from 4-8 mg to 16 mg to 32 mg every 2 weeks unless contraindicated 7
- Both men and women achieved similar mean doses (approximately 21 mg) in clinical trials 7
- 75% of renal transplant patients tolerated gradual uptitration to maximal doses when carefully monitored 8
Important Caveats
Do not exceed 32 mg daily - there is no evidence of additional benefit and this represents the established safety ceiling 1. If blood pressure or heart failure symptoms are inadequately controlled at 32 mg, add complementary agents (such as thiazide diuretics, beta-blockers, or other guideline-directed therapies) rather than exceeding the maximum candesartan dose 2, 1.